A recent study shows that EpHA2 can act as a potential receptor for platelet-derived growth factor subunit A (PDGFA), promoting PDGFA signaling in combination with platelet-derived growth factor receptor alpha (PDGFRA) and mediating resistance of GBM cells to PDGFRA inhibitors [88]. This evidence concerns the gene EPHA2 and glioblastoma.